Skip to main content

Post-traumatic Stress Disorders

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Cognition Therapeutics
Cognition TherapeuticsPA - Pittsburgh
1 program
Simple cognitive taskN/A1 trial
Active Trials
NCT02080351Completed71Est. Mar 2015
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Slow BreathingN/A1 trial
Active Trials
NCT00778960Completed102Est. May 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Cognition TherapeuticsSimple cognitive task
Oregon TherapeuticsSlow Breathing

Clinical Trials (2)

Total enrollment: 173 patients across 2 trials

A Simple Cognitive Task to Reduce the Build-Up of Flashbacks After a Road Traffic Accident

Start: Mar 2014Est. completion: Mar 201571 patients
N/ACompleted

Mechanistic Pathways of Mindfulness Meditation in Post-traumatic Stress Disorder.

Start: Jan 2009Est. completion: May 2014102 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.